Development and Evaluation of a Cryopreserved Whole-Parasite Vaccine in a Rodent Model of Blood-Stage Malaria-Reference-Cited by-同舟云学术

Development and Evaluation of a Cryopreserved Whole-Parasite Vaccine in a Rodent Model of Blood-Stage Malaria

Published:2021-10-26 Issue:5 Volume:12 Page:
ISSN:2150-7511
Container-title:mBio
language:en
Short-container-title:mBio

Author:

Stanisic Danielle I.¹^ORCID,Ho Mei-Fong¹,Nevagi Reshma¹,Cooper Emily¹,Walton Maddison¹,Islam Md Tanjir²,Hussein Waleed M.²,Skwarczynski Mariusz²,Toth Istvan²³⁴,Good Michael F.¹

Affiliation:

1. Institute for Glycomics, Griffith University, Southport, Australia

2. School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Australia

3. School of Pharmacy, The University of Queensland, St Lucia, Australia

4. Institute for Molecular Bioscience, The University of Queensland, St Lucia, Australia

Abstract

Malaria is a mosquito-borne infectious disease that is caused by parasites of the genus, Plasmodium . There are seven different Plasmodium spp. that can cause malaria in humans, with P. falciparum causing the majority of the morbidity and mortality.

Funder

Medical Research Future Fund

Department of Health | National Health and Medical Research Council

Publisher

American Society for Microbiology

Subject

Virology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/mBio.02657-21

Reference42 articles.

1. World Health Organization. 2020. World malaria report 2020. World Health Organization Geneva Switzerland.

2. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial